[go: up one dir, main page]

WO2018107821A1 - Bionic skin and preparation method therefor - Google Patents

Bionic skin and preparation method therefor Download PDF

Info

Publication number
WO2018107821A1
WO2018107821A1 PCT/CN2017/100138 CN2017100138W WO2018107821A1 WO 2018107821 A1 WO2018107821 A1 WO 2018107821A1 CN 2017100138 W CN2017100138 W CN 2017100138W WO 2018107821 A1 WO2018107821 A1 WO 2018107821A1
Authority
WO
WIPO (PCT)
Prior art keywords
product
parts
polydimethylsiloxane
reaction liquid
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2017/100138
Other languages
French (fr)
Chinese (zh)
Inventor
姜舒
张芸
纪惜銮
罗朝霞
杨顺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Wingor Biotechnology Co ltd
Original Assignee
Shenzhen Wingor Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Wingor Biotechnology Co ltd filed Critical Shenzhen Wingor Biotechnology Co ltd
Publication of WO2018107821A1 publication Critical patent/WO2018107821A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to the field of cosmetics, and in particular to a biomimetic skin and a preparation method thereof.
  • the skin is one of the most important organs of the human body. It is a barrier between the human body and the outside world. It protects human tissues and organs from toxic substances, pathogens and microorganisms in the external environment, thus maintaining the stability of the internal environment. It has good permeability and moisture retention, and the physiological state of the skin reflects the individual's health. senescence
  • Biosafety high biocompatibility, application to the skin is not sensitized, does not produce Inflammatory reaction
  • Appropriate viscosity easy to apply on the skin surface, easy to form a film
  • Breathable and moisturizing and waterproof blocking the harmful factors of the external environment
  • biomechanical properties of normal skin such as tensile strength and elasticity, Matches the mechanical response of the skin in daily activities
  • Smooth and thin, good optical effect adhered to the normal skin surface, no obvious connection interface, to achieve an aesthetic effect.
  • existing artificial skin still does not fully possess the functional and physiological properties of natural skin.
  • the present invention is achieved by: a bionic skin comprising a base reactant, an adjuvant and water
  • the emulsion polymerization occurs under the catalytic action of the catalyst to form a crosslinked network structure; wherein the basic reactant accounts for 10-20% of the total mass of the reactant, and the auxiliary agent accounts for 40-55% of the total mass of the reactant, and the rest Is water;
  • the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of fumed silica and 17-36 parts of active hydrogen-containing polysiloxane;
  • the catalyst is a Karstedt platinum catalyst, and the platinum content of the catalyst is 1-5%;
  • the auxiliary agent includes a viscosity reducing agent for reducing the stickiness of the product, an emulsifier for increasing the degree of emulsification of the product, and a moisturizing agent for increasing the surface moisture of the skin.
  • the viscosity reducing agent comprises polydimethylsiloxane One or both of an alkane and a trisiloxane, a polydimethylsiloxane;
  • the emulsifier comprises a polydimethylsiloxane/PEG-10/15 crosslinked polymer and a decamethylcyclopentane Silicone, diisobutyl PEG/PPG-10/7/polydimethylsiloxane One or two of the polymers;
  • the humectant includes phenoxyethanol, a diol mixture of pentanediol and octylene glycol 1:1, one or more of propylene glycol, butylene glycol, and glycerin;
  • the pH adjusting agent is sodium
  • the artificial skin provided by the present solution is safe and reliable, and the existing literature records indicate that the formulation components involved in the invention have safety and biocompatibility, and are not sensitized and inflammatory.
  • polydimethylsiloxane and trisiloxane refers to a material instead of “polydimethylsiloxane” and “trisiloxane”. Alkane "two materials.
  • polydimethylsiloxane/PEG-1 0/15 crosslinked polymer and decamethylcyclopentasiloxane, decamethylcyclopentasiloxane and polydimethylsiloxane polymer, poly The dimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane also refer to one substance, respectively.
  • the vinyl terminated polydimethylsiloxane is a mixture of Andisil VS200 product and VS 10 product; the active hydrogen group-containing polysiloxane is Andisil XL-11 product; the Karstedt platinum catalyst is a product of AB Specialty Silicones; the polydimethylsiloxane and trisiloxane are products of Dow Corning Corporation PMX-1184; the polydimethylsiloxane Dow Corning Corporation PMX-200 product; the polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane are Shin-Etsu Chemical Corporation KSG-240 products; Isobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer is Dow Corning Corporation FZ-2233 product; acrylate/C10-30 alkyl acrylate crosspolymer is Lubrizol
  • the same Chinese chemical name may correspond to two different specific products.
  • the "vinyl-terminated polydimethylsiloxane plant" in this scheme uses Andisil Company respectively.
  • Both the V S200 and VS10 products, which are vinyl-terminated polydimethylsiloxanes, have different vinyl contents and therefore have different viscosities that affect the properties of the artificial skin provided by this solution.
  • Another object of the present invention is to provide a method for preparing bionic skin.
  • the method includes the following steps,
  • Step A preparing a first reaction liquid;
  • the first reaction liquid comprises a homogeneously mixed base reactant, water and an auxiliary agent; wherein the basic reactant accounts for 25-36% of the total mass of the first reaction liquid, The auxiliary agent accounts for 15-25% of the total mass of the first reaction liquid, and the balance is water;
  • the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of gas phase method Silica and 17-36 parts of active hydrogen group-containing polysiloxane;
  • Step B preparing a second reaction liquid;
  • the second reaction liquid comprises a uniformly mixed catalyst, water and a solvent; wherein the catalyst mass accounts for 0.5-3% of the total mass of the second reaction liquid, The auxiliary agent accounts for 60-80% of the total mass of the second reaction liquid, and the balance is water;
  • the catalyst is a Karstedt platinum catalyst, and the platinum content of the catalyst is 1-5%;
  • Step C applying the first reaction solution to the skin
  • Step D applying the second reaction solution to the area of the step C in which the first reaction liquid is applied,
  • the reaction forms artificial skin;
  • the second reaction solution has a smear mass of 1-2 times that of the first reaction solution.
  • step A includes the following sub-steps,
  • Step A1 preparing a main reaction solution; the main reaction solution is obtained by uniformly mixing a base reactant, a viscosity reducer for reducing the stickiness of the product, and an emulsifier for increasing the degree of emulsification of the product; Includes 7-10 parts of Andisil's vinyl terminated polydimethylsiloxane VS
  • Step A2 preparing a diluted solution: the diluted solution is obtained by uniformly mixing a thickener, a moisturizer that increases the surface moisture of the skin, and water;
  • Step A3 preparing a first reaction liquid; the first reaction liquid is formed by slowly adding the diluted solution to the main reaction solution until a white creamy emulsion is formed.
  • a further technical solution of the present invention is:
  • the step A further comprises the substep A4: adding a pH adjuster and adjusting the first reaction solution to a pH of 5.5-6.6.
  • the pH can be adjusted by a 10N sodium hydroxide solution.
  • step B includes the following sub-steps
  • Step B1 preparing a thickening solution formed by uniformly mixing a thickener which increases the viscosity of the product, a spreading agent for improving the spreading property of the product, and an emulsifier which increases the degree of emulsification of the product;
  • Step B2 preparing a moisturizing solution composed of water and a moisturizing agent that increases the surface moisture of the skin;
  • Step B3 preparing a second reaction liquid; the second reaction liquid is obtained by slowly adding the moisturizing solution to the thickening solution until a clear emulsion is formed, and then adding a catalyst.
  • a further technical solution of the present invention is: adding 3-7 parts of a beautifying agent for enhancing product dispersibility and improving aesthetic effect before adding the catalyst in the step B3;
  • the beautifying agent is isopropyl triisostearate Oxygen titanium salt modified nylon.
  • the viscosity reducing agent comprises 10-14 parts of Dow Coming Corporation polydimethylsiloxane and trisiloxane PMX-1184 product, Dow Coming Corporation polydimethyl Silicone PMX-200 product 1-5 parts;
  • the emulsifier includes Shin-Etsu Chemical Corporation polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane KSG - 240 products 3-7 parts, Dow Corning Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-2233 product 0.05-0.3 parts;
  • the thickener includes Lubrizol Corporation 0.1-0.7 parts of acrylate/C10-30 alkyl acrylate cross-linked polymer Pemulen TR-2, Lubrizol Corporation acrylate/C10-30 alkyl acrylate cross-linked polymer Ultrez 20 product 0.1-0.7 parts
  • the humectant comprises 0.1-0.5 parts of
  • the thickener comprises 8-13 parts of Dow Coming Corporation's decamethylcyclopentasiloxane and polydimethylsiloxane polymer DC9045 product, Dow Corning Corporation Polydimethylsiloxane cross-linking copolymer and 1-5 parts of cyclopentamethylsiloxane DC9040 product, 0.3-0.7 parts of sodium chloride;
  • the spreading agent includes ring-polydimethylene of Shin-Etsu Chemical Corporation 13-18 parts of the base silicone KF-995 product, 0.1-3 parts of the cyclopentadimethylsiloxane PMX-0245 product of Dow Corning Corporation;
  • the humectant includes 0.1-0.7 parts of phenoxyethanol, 3-7 parts of a diol mixture of alcohol and octylene glycol 1:1, 8-13 parts of propylene glycol, 8-13 parts of butanediol, and 3-8 parts of glycerin;
  • the emulsifier includes Shin
  • the beneficial effects of the present invention are:
  • the first reaction liquid in the solution can be closely adhered to the skin, and after the second reaction liquid is applied, the silicone component can be crosslinked under the action of the platinum catalyst to form a strong network structure.
  • the bionic skin cosmetics formed are washable and waterproof, and have the biomechanical properties of normal skin. The only need to directly remove the cockroaches is to remove the cockroaches, which is convenient and safe, and is quick to prepare.
  • the program has the following advantages: 1) The existing literature records indicate that the formulation components involved in the invention have safety and biocompatibility, no sensitization and inflammation; 2) suitable viscosity, easy to spread evenly on the skin surface, easy Film formation; 3) good biomechanical properties, such as tensile modulus, adhesion, shrinkage, etc.; 4) good breathability and moisturizing properties, washable and waterproof, can block the harmful factors of the outside; 5) preparation of the patented method of the present invention
  • the surface of the bionic skin is smooth and only 75 microns thick.
  • the added NylonlO-12 has good optical effect, which can make the bionic skin perfectly combine with the human skin surface without obvious connecting lines.
  • the bionic skin prepared by the method of the invention can be applied to human skin to make the skin smooth and elastic, and less Light wrinkles.
  • the present invention firstly provides a biomimetic skin, which is formed by emulsion polymerization of a base reactant, an auxiliary agent and water under the catalytic action of a catalyst to form a crosslinked network structure; wherein the base reactant accounts for 10-20% of the total mass of the reactants, the adjuvant is 40-55% of the total mass of the reactants, the balance being water; the base reactant comprises 47-60 parts of vinyl terminated polydimethylsiloxane 20-29 parts of fumed silica and 17-36 parts of active hydrogen group-containing polysiloxane; the catalyst is a Karstedt platinum catalyst, and the catalyst has a platinum content of 1-5%;
  • the agent includes a viscosity reducing agent for reducing the stickiness of the product, an emulsifier for increasing the degree of emulsification of the product, a moisturizing agent for increasing the surface moisture of the skin, a pH adjuster for adjusting the pH of the product, a thickener for increasing the visco
  • the viscosity reducing agent comprising one or both of polydimethylsiloxane and trisiloxane, polydimethylsiloxane;
  • Emulsifiers include polydimethylsiloxane/PE One or both of G-10/15 crosslinked polymer and decamethylcyclopentasiloxane, diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer;
  • the humectant comprises a mixture of phenoxyethanol, pentanediol and octylene glycol 1:1, a propylene glycol, a butanediol, a glycerin;
  • the pH adjuster is sodium hydroxide;
  • Thickeners include acrylate/C10-30 alkyl acrylate crosspolymer, decamethylcyclopentasiloxane and polydimethylsiloxane a polymer, a polyd
  • the artificial skin provided by the present solution is safe and reliable, and the existing literature records indicate that the formulation components of the present invention have safety and biocompatibility, and are not sensitized and inflammatory.
  • polydimethylsiloxane and trisiloxane refers to a material instead of “polydimethylsiloxane” and “trisiloxane”. Alkane "two materials.
  • polydimethylsiloxane/PEG-1 0/15 crosslinked polymer and decamethylcyclopentasiloxane, decamethylcyclopentasiloxane and polydimethylsiloxane polymer, poly The dimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane also refer to one substance, respectively.
  • the vinyl terminated polydimethylsiloxane is a mixture of Andisil VS200 product and VS10 product; the active hydrogen group-containing polysiloxane is Andisil XL-11 product;
  • the Karst edt platinum catalyst is a product of AB Specialty Silicones;
  • the polydimethylsiloxane and trisiloxane are products of Dow Corning Corporation PMX-1184;
  • the polydimethylsiloxane is Dow Coming Corporation PMX-200 product;
  • the polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane are products of Shin-Etsu Chemical Corporation KSG-240; PEG/PPG-10/7/polydimethylsiloxane copolymer for Dow Corning
  • acrylate/C 10-30 alkyl acrylate crosspolymer is a mixture of Lubri zol Corporation Pemulen TR-2 product and Ultrez 20 product; the decamethylcyclopentasiloxane and The polydimethylsiloxane polymer is a Dow Corning Corporation DC9045 product; the polydimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane are Dow Corning
  • the present invention also discloses a method of producing bionic skin.
  • the method includes the following steps,
  • Step A preparing a first reaction liquid; the first reaction liquid includes a homogeneously mixed base reactant, water And an auxiliary agent; wherein the basic reactant accounts for 25-36% of the total mass of the first reaction liquid, the auxiliary agent accounts for 15-25% of the total mass of the first reaction liquid, and the rest is water; the basic reactant includes 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of fumed silica, and 17-36 parts of active hydrogen-containing polysiloxane; [0041] Step A includes the following Step by step,
  • Step A1 preparing a main reaction solution; the main reaction solution is obtained by uniformly mixing a base reactant, a viscosity reducer for reducing the stickiness of the product, and an emulsifier for increasing the degree of emulsification of the product; Includes 7-10 parts of Andisil's vinyl terminated polydimethylsiloxane VS
  • Step A2 preparing a diluted solution: the diluted solution is obtained by uniformly mixing a thickener, a moisturizer that increases the surface moisture of the skin, and water;
  • Step A3 preparing a first reaction liquid; the first reaction liquid is formed by slowly adding the diluted solution to the main reaction solution until a white creamy emulsion is formed.
  • Step A4 A pH adjuster is added and the first reaction solution is adjusted to a pH of 5.5-6.6.
  • the pH can be adjusted by a 10N sodium hydroxide solution.
  • the viscosity reducing agent comprises Dow Corning Corporation polydimethylsiloxane and trisiloxane PMX-1184 product 10-14 parts, Dow Coming
  • the emulsifier includes Shin-Etsu Chemical Corporation polydimethylsiloxane / PEG-10 / 15 cross-linked polymer and decamethyl 3-7 parts of cyclopentasiloxane KSG-240 product, Dow Corning Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-2233 product 0.05-0.3 parts; Thickeners include Lubrizol Corporation acrylate/C10-30 alkyl acrylate crosspolymer PEmulen
  • the humectant includes phenoxyethanol 0.1-0.5 parts, pentylene 0.1-0.5 parts of a mixture of alcohol and octylene glycol 1:1
  • Step B preparing a second reaction liquid;
  • the second reaction liquid comprises a uniformly mixed catalyst, water and a solvent; wherein the catalyst mass accounts for 0.5-3% of the total mass of the second reaction liquid, The auxiliary agent accounts for 60-80% of the total mass of the second reaction liquid, and the balance is water;
  • the catalyst is a Karstedt platinum catalyst, the catalyst The platinum content is 1-5%;
  • the step B includes the following sub-steps,
  • Step B1 preparing a thickening solution formed by uniformly mixing a thickener which increases the viscosity of the product, a spreading agent for improving the spreading property of the product, and an emulsifier which increases the degree of emulsification of the product;
  • Step B2 preparing a moisturizing solution composed of water and a moisturizing agent that increases the surface moisture of the skin;
  • Step B3 preparing a second reaction liquid; the second reaction liquid is obtained by slowly adding the moisturizing solution to the thickening solution until a clear emulsion is formed, and then adding a catalyst.
  • a beautifying agent for enhancing product dispersibility and improving aesthetic effect are added before the catalyst is added in the step B3;
  • the beautifying agent is nylon modified with isopropoxytitanate.
  • the thickener includes 8-13 parts of Dow Corning Corporation's decamethylcyclopentasiloxane and polydimethylsiloxane polymer DC9045 product, Dow Corning Corporation polydimethylsiloxane 1-3 parts of a copolymer and a cyclopentamethylsiloxane DC9040 product, and 0.3-0.7 parts of sodium chloride;
  • the spreading agent includes a cyclopentadimethylsiloxane KF-995 product of Shin-Etsu Chemical Corporation 13- 18 parts, Dow Corning Corporation, 5-penta-dimethylsiloxane PMX-0245 product 0.1-3 parts;
  • the humectant includes phenoxyethanol 0.1-0.7 parts, pentanediol and octylene glycol 1: 1 3-7 parts of the diol mixture, 8-13 parts of propylene glycol, 8-13 parts of butanediol, and 3-8 parts of glycerin;
  • Step C applying the first reaction solution to the skin
  • Step D applying the second reaction solution to the area where the first reaction liquid is applied in the step C, and reacting to form artificial skin; the application quality of the second reaction liquid is the first reaction 1-2 times the liquid.
  • a in the mixer 31.0% of the base reactant, 12.0 ⁇ 3 ⁇ 4PMX-1184 (polydimethylsiloxane and trisiloxane), 2.0% PMX-200 (polydimethylsiloxane), 5.0% KSG-240 (polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane), 0.1 ⁇ 3 ⁇ 4FZ -2233 (diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer) Mix well.
  • step b The mixture obtained in step b was slowly added to the mixture obtained in the step a until a white creamy emulsion was formed, and 0.2% 10N sodium hydroxide solution was added thereto, and the pH was adjusted to 5.5 to 6.5.
  • DC9040 polydimethylsiloxane cross-linked copolymer and cyclopentamethylsiloxane
  • 5.0 ⁇ 3 ⁇ 4KSG-240 polydimethylsiloxane/PEG-10/15 cross-linked polymer and decamethyl Cyclopentasiloxane
  • 0.2% FZ-2233 diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer
  • 15.0% KF-995 cyclopentadimethylsiloxane) Alkane
  • PMX-0245 cyclopentadimethylsiloxane
  • 0.5% sodium chloride 5.0% glycerol mixed evenly
  • e in the mixer 4 30.0% water, 0.3% phenoxyethanol, 5.0% diol mixture (pentylene glycol and octylene glycol, 1:1), 10.0% propylene glycol, 10.0% butanediol well mixed.
  • step f The mixture obtained in step e is slowly dropped into the mixture obtained in step d until a clear emulsion is formed, then 5.0 ⁇ 3 ⁇ 4 NylonlO-12 is slowly added to the emulsion to be homogeneously mixed, and finally 1.0% Karstedt platinum catalyst solution is added (including 2.0% platinum) and mix well.
  • the ratio of the emulsion 1 and the emulsion 2 is 2:3, the emulsion 1 is applied first, and then the emulsion 2 is applied.
  • the emulsion 1 can be closely adhered to the skin, and the silicone component is coated with the platinum catalyst after the emulsion 2 is applied. Under the action, it can be cross-linked to form a firm network structure, and the formed bionic skin cosmetics are washable and waterproof, and have the biomechanical properties of normal skin. To remove the crucible, just tear it.
  • the tensile modulus was 0.45 MPa, the strain at break was 800%, and the adhesion strength was 78 N mm -1 .
  • the tensile test showed that the tensile modulus of normal skin at 40% strain was 0.5-1.95 MPa, and the bionic skin cosmetic prepared by the method of the present invention had a tensile modulus of 0.5 MPa and a strain at break of 240%. Therefore, the artificial skin provided by this program has good elasticity.
  • the transepidermal water loss (TEWL) test showed that the TEWL of the bionic skin cosmetic prepared by the method of the present invention decreased by 20% after 24 hours of application (4.0 g/m 3 ⁇ 4, 3.2 g/m 3 ⁇ 4 before and after application for 24 hours). )
  • the artificial skin provided by the present solution has the following advantages: 1)
  • the existing literature records indicate that the formulation components of the present invention have safety and biocompatibility, and are not sensitized and inflammatory; 2 Appropriate viscosity, easy to spread on the skin surface, easy to form a film; 3) good biomechanical properties, such as tensile modulus, adhesion, shrinkage, etc.; 4) good breathability and moisturizing properties, washable and waterproof, can block the outside world Invasion of harmful factors; 5)
  • the bionic skin prepared by the patented method of the invention has a smooth surface and a thickness of only 75 ⁇ m, and the added Nylonl O-12 has a good optical effect, so that the bionic skin can be perfectly combined with the surface of the human skin without obvious connection. Boundary.
  • the bionic skin prepared by the method of the invention can be applied to human skin to make the skin smooth, elastic and wrinkle-reducing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

A bionic skin, the bionic skin being formed by means of emulsion polymerization of a basic reactant, an additive and water, which occurs under the catalytic action of a catalyst to form a cross-linked network structure. Applying the bionic skin to human skin may cause the skin to be smooth and elastic, and may reduce wrinkles.

Description

一种仿生皮肤及其制备方法 技术领域  Bionic skin and preparation method thereof

[0001] 本发明涉及化妆品领域, 尤其涉及一种仿生皮肤及其制备方法。  [0001] The present invention relates to the field of cosmetics, and in particular to a biomimetic skin and a preparation method thereof.

背景技术  Background technique

[0002] 随着科技水平的进步, 人们的生活质量也越来越高。 人们对美的追求, 尤其是 对自身相貌美丽的追求越来越强烈。  [0002] With the advancement of technology, people's quality of life is getting higher and higher. People's pursuit of beauty, especially the pursuit of their own beauty is getting stronger and stronger.

[0003] 皮肤是人体最重要的器官之一,是人体与外界的一道屏障,保护人体组织和器官 不受外界环境中有毒物质、 病原体、 微生物等的侵害,从而维持内环境的稳定, 同吋具有很好的通透性和保湿性,皮肤的生理状态体现着个体的健康状态。 衰老 [0003] The skin is one of the most important organs of the human body. It is a barrier between the human body and the outside world. It protects human tissues and organs from toxic substances, pathogens and microorganisms in the external environment, thus maintaining the stability of the internal environment. It has good permeability and moisture retention, and the physiological state of the skin reflects the individual's health. senescence

、 外环境侵害、 疾病等可引起皮肤正常生理功能障碍, 进而导致生活质量下降 、 情绪障碍等。 皮肤衰老是每个人都会面临的问题, 衰老导致皮肤丧失弹性回 缩功能而变得松弛, 目前仍无根治的方法。 External environmental aggression, diseases, etc. can cause normal physiological dysfunction of the skin, which in turn leads to a decline in quality of life and mood disorders. Skin aging is a problem that everyone faces. The aging causes the skin to lose its elastic retraction function and becomes slack. There is still no cure.

[0004] 为此, 组织工程学在近年来逐渐发展出人工仿生皮肤, 高品质的仿生皮肤必须 具备以下特性 :1)具备生物安全性,生物相容性高,应用于皮肤不致敏,不产生炎症反 应; 2)粘度适宜,在皮肤表面易涂抹,易成膜 ;3)透气保湿且防水, 阻挡外界环境的有 害因素; 4)具备正常皮肤拥有的生物力学性能, 如拉伸强度和弹性,与日常活动 中皮肤的力学反应相匹配; 5)平滑且薄,光学效果佳,粘贴在正常皮肤表面, 无明 显的连接界面, 达到美观的效果。 但是现有的人工皮肤仍然无法完全具备天然 皮肤具备的功能性和生理学性能。 [0004] For this reason, tissue engineering has gradually developed artificial bionic skin in recent years. High-quality bionic skin must have the following characteristics: 1) Biosafety, high biocompatibility, application to the skin is not sensitized, does not produce Inflammatory reaction; 2) Appropriate viscosity, easy to apply on the skin surface, easy to form a film; 3) Breathable and moisturizing and waterproof, blocking the harmful factors of the external environment; 4) With the biomechanical properties of normal skin, such as tensile strength and elasticity, Matches the mechanical response of the skin in daily activities; 5) Smooth and thin, good optical effect, adhered to the normal skin surface, no obvious connection interface, to achieve an aesthetic effect. However, existing artificial skin still does not fully possess the functional and physiological properties of natural skin.

技术问题  technical problem

[0005] 在此处键入技术问题描述段落。  [0005] Type the technical problem description paragraph here.

问题的解决方案  Problem solution

技术解决方案  Technical solution

[0006] 本发明的目的在于提供一种仿生皮肤, 旨在解决现有仿生皮肤安全性能差的问 题。  [0006] It is an object of the present invention to provide a bionic skin which is intended to solve the problem of poor safety performance of existing bionic skin.

[0007] 本发明是这样实现的: 一种仿生皮肤, 所述仿生皮肤由基础反应物、 助剂和水 在催化剂的催化作用下发生乳液聚合形成交联网状结构而成; 其中所述基础反 应物占反应物总质量的 10-20%, 所述助剂占反应物总质量的 40-55%, 其余为水 ; 所述基础反应物包括 47-60份乙烯基封端的聚二甲基硅氧烷、 20-29份的气相法 白炭黑和 17-36份含活性氢基的聚硅氧烷; 所述催化剂为 Karstedt铂催化剂, 所述 催化剂的含铂量为 1-5% ; 所述助剂包括降低产品粘腻感的降粘剂、 增加产品乳 化程度的乳化剂、 增加皮肤表面湿度的保湿剂、 调节产品酸碱度的 pH调节剂、 增加产品粘度的增稠剂、 改善产品铺张性能的铺展剂以及增强产品分散性和提 高美学效果的美化剂; 所述降粘剂包括聚二甲基硅氧烷和三硅氧烷、 聚二甲基 硅氧烷中的一种或两种; 所述乳化剂包括聚二甲基硅氧院 /PEG-10/15交联聚合物 和十甲基环五硅氧烷、 二异丁基 PEG/PPG- 10/7/聚二甲基硅氧烷共聚物中的一种 或两种; 所述保湿剂包括苯氧乙醇、 戊二醇和辛乙二醇 1: 1的二醇混合物、 丙二 醇、 丁二醇、 甘油中的一种或多种; 所述 pH调节剂为氢氧化钠; 所述增稠剂包 括丙烯酸酯 /C10-30烷基丙烯酸酯交联聚合物、 十甲基环五硅氧烷和聚二甲基硅 氧烷聚合物、 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷、 氯化钠中的一种 或多种; 所述铺展剂为环五聚二甲基硅氧烷; 所述美化剂为三异硬脂酸异丙氧 钛盐修饰的尼龙 12。 通过上述材料制备一种人造皮肤。 通过基础反应物形成人 造皮肤骨架, 通过加入助剂改变人造皮肤的性能。 The present invention is achieved by: a bionic skin comprising a base reactant, an adjuvant and water The emulsion polymerization occurs under the catalytic action of the catalyst to form a crosslinked network structure; wherein the basic reactant accounts for 10-20% of the total mass of the reactant, and the auxiliary agent accounts for 40-55% of the total mass of the reactant, and the rest Is water; the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of fumed silica and 17-36 parts of active hydrogen-containing polysiloxane; The catalyst is a Karstedt platinum catalyst, and the platinum content of the catalyst is 1-5%; the auxiliary agent includes a viscosity reducing agent for reducing the stickiness of the product, an emulsifier for increasing the degree of emulsification of the product, and a moisturizing agent for increasing the surface moisture of the skin. a pH adjuster for adjusting the pH of the product, a thickener for increasing the viscosity of the product, a spreading agent for improving the spreading properties of the product, and a beautifying agent for enhancing the dispersibility of the product and improving the aesthetic effect; the viscosity reducing agent comprises polydimethylsiloxane One or both of an alkane and a trisiloxane, a polydimethylsiloxane; the emulsifier comprises a polydimethylsiloxane/PEG-10/15 crosslinked polymer and a decamethylcyclopentane Silicone, diisobutyl PEG/PPG-10/7/polydimethylsiloxane One or two of the polymers; the humectant includes phenoxyethanol, a diol mixture of pentanediol and octylene glycol 1:1, one or more of propylene glycol, butylene glycol, and glycerin; The pH adjusting agent is sodium hydroxide; the thickener comprises acrylate/C10-30 alkyl acrylate crosspolymer, decamethylcyclopentasiloxane and polydimethylsiloxane polymer, poly a dimethylsiloxane crosslinked copolymer and one or more of cyclopentamethylsiloxane and sodium chloride; the spreading agent is cyclopentadimethylsiloxane; the beautifying agent is Nylon 12 modified with isopropoxytitanium triisostearate. An artificial skin is prepared from the above materials. The artificial skin skeleton is formed by the base reactant, and the properties of the artificial skin are changed by adding an adjuvant.

[0008] 本方案提供的人造皮肤安全可靠, 现有的文献资料记载表明本发明专利涉及的 配方成分具备安全性和生物相容性,无致敏致炎。  [0008] The artificial skin provided by the present solution is safe and reliable, and the existing literature records indicate that the formulation components involved in the invention have safety and biocompatibility, and are not sensitized and inflammatory.

[0009] 需要指出的是, 本方案中提到的"聚二甲基硅氧烷和三硅氧烷"是指一种材料, 而不是 "聚二甲基硅氧烷"和"三硅氧烷"两种材料。 同样, 聚二甲基硅氧院 /PEG-1 0/15交联聚合物和十甲基环五硅氧烷、 十甲基环五硅氧烷和聚二甲基硅氧烷聚合 物、 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷也同样分别代指一种物质。  [0009] It should be noted that the "polydimethylsiloxane and trisiloxane" mentioned in the present scheme refers to a material instead of "polydimethylsiloxane" and "trisiloxane". Alkane "two materials. Similarly, polydimethylsiloxane/PEG-1 0/15 crosslinked polymer and decamethylcyclopentasiloxane, decamethylcyclopentasiloxane and polydimethylsiloxane polymer, poly The dimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane also refer to one substance, respectively.

[0010] 本发明的进一步技术方案是: 所述乙烯基封端的聚二甲基硅氧烷为 Andisil公司 VS200产品和 VS 10产品的混合物; 所述含活性氢基的聚硅氧烷为 Andisil公司 XL- 11产品; 所述 Karstedt铂催化剂为 AB Specialty Silicones公司产品; 所述聚二甲基 硅氧烷和三硅氧烷为 Dow Corning Corporation公司 PMX-1184产品; 所述聚二甲 基娃氧院为 Dow Corning Corporation公司 PMX-200产品; 所述聚二甲基硅氧院 /PEG-10/15交联聚合物和十 甲基环五硅氧烷为 Shin-Etsu Chemical Corporation公司 KSG-240产品; 所述二异丁 基 PEG/PPG-10/7/聚二甲基硅氧烷共聚物为 Dow Corning Corporation公司 FZ-2233 产品; 丙烯酸酯 /C10-30烷基丙烯酸酯交联聚合物为 Lubrizol [0010] A further technical solution of the present invention is: the vinyl terminated polydimethylsiloxane is a mixture of Andisil VS200 product and VS 10 product; the active hydrogen group-containing polysiloxane is Andisil XL-11 product; the Karstedt platinum catalyst is a product of AB Specialty Silicones; the polydimethylsiloxane and trisiloxane are products of Dow Corning Corporation PMX-1184; the polydimethylsiloxane Dow Corning Corporation PMX-200 product; the polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane are Shin-Etsu Chemical Corporation KSG-240 products; Isobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer is Dow Corning Corporation FZ-2233 product; acrylate/C10-30 alkyl acrylate crosspolymer is Lubrizol

Corporation公司 Pemulen TR-2产品和 Ultrez 20产品的混合物; 所述十甲基环五硅 氧烷和聚二甲基硅氧烷聚合物为 Dow Corning Corporation公司 DC9045产品; 所述 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷为 Dow Corning  a mixture of the company's Pemulen TR-2 product and the Ultrez 20 product; the decamethylcyclopentasiloxane and polydimethylsiloxane polymer are Dow Corning Corporation DC9045 product; the polydimethylsiloxane Alkyl Crosslinking Copolymer and Cyclopentamethylsiloxane for Dow Corning

Corporation公司 DC9040产品; 所述环五聚二甲基硅氧烷为 Dow Corning  Corporation DC9040 product; the cyclopentasiloxane is Dow Corning

Corporation公司 PMX-0245产品和 Shin-Etsu Chemical Corporation公司 KF-995产品 的混合物; 所述三异硬脂酸异丙氧钛盐修饰的尼龙 12为 Kobo Products公司 NylonlO-12产品。  A mixture of PMX-0245 product of Corporation and KF-995 product of Shin-Etsu Chemical Corporation; the nylon 12 modified with isopropoxysulphate is Kobo Products NylonlO-12 product.

[0011] 需要说明的是, 本方案中同一个中文化学物名称下可能会对应两种不同的具体 产品, 例如本方案中 "乙烯基封端的聚二甲基硅氧院"分别使用了 Andisil公司的 V S200产品和 VS10产品, 这两种产品都是乙烯基封端的聚二甲基硅氧烷, 但是乙 烯基含量不同, 因此具有不同的粘度, 会对本方案提供的人造皮肤的性质造成 影响。  [0011] It should be noted that in the present scheme, the same Chinese chemical name may correspond to two different specific products. For example, the "vinyl-terminated polydimethylsiloxane plant" in this scheme uses Andisil Company respectively. Both the V S200 and VS10 products, which are vinyl-terminated polydimethylsiloxanes, have different vinyl contents and therefore have different viscosities that affect the properties of the artificial skin provided by this solution.

[0012] 本发明的另一目的在于提供一种仿生皮肤的制备方法。  Another object of the present invention is to provide a method for preparing bionic skin.

[0013] 该方法包括以下步骤, [0013] The method includes the following steps,

[0014] 步骤 A: 制备第一反应液; 所述第一反应液包括均匀混合的基础反应物、 水 和助剂; 其中所述基础反应物占第一反应液总质量的 25-36%, 所述助剂占第一 反应液总质量的 15-25%, 其余为水; 所述基础反应物包括 47-60份乙烯基封端的 聚二甲基硅氧烷、 20-29份的气相法白炭黑和 17-36份含活性氢基的聚硅氧烷; [0014] Step A: preparing a first reaction liquid; the first reaction liquid comprises a homogeneously mixed base reactant, water and an auxiliary agent; wherein the basic reactant accounts for 25-36% of the total mass of the first reaction liquid, The auxiliary agent accounts for 15-25% of the total mass of the first reaction liquid, and the balance is water; the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of gas phase method Silica and 17-36 parts of active hydrogen group-containing polysiloxane;

[0015] 步骤 B : 制备第二反应液; 所述第二反应液包括均匀混合的催化剂、 水和助 齐 1J ; 其中催化剂质量占所述第二反应液总质量的 0.5-3%, 所述助剂占所述第二反 应液总质量的 60-80%, 其余为水; 所述催化剂为 Karstedt铂催化剂, 所述催化剂 的含铂量为 1-5% ; [0015] Step B: preparing a second reaction liquid; the second reaction liquid comprises a uniformly mixed catalyst, water and a solvent; wherein the catalyst mass accounts for 0.5-3% of the total mass of the second reaction liquid, The auxiliary agent accounts for 60-80% of the total mass of the second reaction liquid, and the balance is water; the catalyst is a Karstedt platinum catalyst, and the platinum content of the catalyst is 1-5%;

[0016] 步骤 C: 将所述第一反应液涂抹于皮肤上;  [0016] Step C: applying the first reaction solution to the skin;

[0017] 步骤 D: 将所述第二反应液涂抹于步骤 C中涂抹了所述第一反应液的区域上, 反应形成人造皮肤; 所述第二反应液的涂抹质量为所述第一反应液的 1-2倍。 [0017] Step D: applying the second reaction solution to the area of the step C in which the first reaction liquid is applied, The reaction forms artificial skin; the second reaction solution has a smear mass of 1-2 times that of the first reaction solution.

[0018] 本发明的进一步技术方案是: 所述步骤 A包括以下分步骤, [0018] A further technical solution of the present invention is: the step A includes the following sub-steps,

[0019] 步骤 A1 : 制备主反应溶液; 所述主反应溶液由基础反应物、 降低产品粘腻感 的降粘剂和增加产品乳化程度的乳化剂均匀混合后获得; 所述基础反应物中包 含包括 7-10份 Andisil公司乙烯基封端的聚二甲基硅氧烷 VS [0019] Step A1: preparing a main reaction solution; the main reaction solution is obtained by uniformly mixing a base reactant, a viscosity reducer for reducing the stickiness of the product, and an emulsifier for increasing the degree of emulsification of the product; Includes 7-10 parts of Andisil's vinyl terminated polydimethylsiloxane VS

200产品、 40-50份 Andisil公司乙烯基封端的聚二甲基硅氧烷 VS 10产品、 20-29份 的气相法白炭黑和 17-36份含活性氢基的聚硅氧烷;  200 products, 40-50 parts of Andisil's vinyl terminated polydimethylsiloxane VS 10 product, 20-29 parts of fumed silica and 17-36 parts of active hydrogen-containing polysiloxane;

[0020] 步骤 A2: 制备稀释溶液: 所述稀释溶液由增稠剂、 增加皮肤表面湿度的保湿 剂和水均匀混合后获得; [0020] Step A2: preparing a diluted solution: the diluted solution is obtained by uniformly mixing a thickener, a moisturizer that increases the surface moisture of the skin, and water;

[0021] 步骤 A3: 制备第一反应液; 所述第一反应液系将所述稀释溶液缓慢添加到所述 主反应溶液中至形成白色奶油状乳液后形成。 [0021] Step A3: preparing a first reaction liquid; the first reaction liquid is formed by slowly adding the diluted solution to the main reaction solution until a white creamy emulsion is formed.

[0022] 本发明的进一步技术方案是: 所述步骤 A还包括分步骤 A4: 加入 pH调节剂并调 节所述第一反应液至 pH值为 5.5-6.6。 本方案可以通过浓度为 10N的氢氧化钠溶液 对 pH值进行调节。 [0022] A further technical solution of the present invention is: The step A further comprises the substep A4: adding a pH adjuster and adjusting the first reaction solution to a pH of 5.5-6.6. In this scheme, the pH can be adjusted by a 10N sodium hydroxide solution.

[0023] 本发明的进一步技术方案是: 所述步骤 B包括以下分步骤, [0023] A further technical solution of the present invention is: the step B includes the following sub-steps,

[0024] 步骤 B1 : 制备增稠溶液, 所述增稠溶液由增加产品粘度的增稠剂、 改善产品 铺张性能的铺展剂以及增加产品乳化程度的乳化剂均匀混合后形成; [0024] Step B1: preparing a thickening solution formed by uniformly mixing a thickener which increases the viscosity of the product, a spreading agent for improving the spreading property of the product, and an emulsifier which increases the degree of emulsification of the product;

[0025] 步骤 B2: 制备保湿溶液, 所述保湿溶液由水和增加皮肤表面湿度的保湿剂组 成; [0025] Step B2: preparing a moisturizing solution composed of water and a moisturizing agent that increases the surface moisture of the skin;

[0026] 步骤 B3:制备第二反应液; 所述第二反应液系将所述保湿溶液缓慢滴加到所述 增稠溶液中至形成清澈乳液后再加入催化剂获得。  [0026] Step B3: preparing a second reaction liquid; the second reaction liquid is obtained by slowly adding the moisturizing solution to the thickening solution until a clear emulsion is formed, and then adding a catalyst.

[0027] 本发明的进一步技术方案是: 所述步骤 B3中加入所述催化剂之前加入 3-7份增 强产品分散性和提高美学效果的美化剂; 所述美化剂为三异硬脂酸异丙氧钛盐 修饰的尼龙。 [0027] A further technical solution of the present invention is: adding 3-7 parts of a beautifying agent for enhancing product dispersibility and improving aesthetic effect before adding the catalyst in the step B3; the beautifying agent is isopropyl triisostearate Oxygen titanium salt modified nylon.

[0028] 本发明的进一步技术方案是: 所述降粘剂包括 Dow Coming Corporation公司聚 二甲基硅氧烷和三硅氧烷 PMX- 1184产品 10- 14份、 Dow Coming Corporation公司 聚二甲基硅氧烷 PMX-200产品 1-5份; 所述乳化剂包括 Shin-Etsu Chemical Corporation公司聚二甲基硅氧院 /PEG-10/15交联聚合物和十甲基环五硅氧烷 KSG- 240产品 3-7份、 Dow Corning Corporation公司二异丁基 PEG/PPG- 10/7/聚二甲基硅 氧烷共聚物 FZ-2233产品 0.05-0.3份; 所述增稠剂包括 Lubrizol Corporation公司丙 烯酸酯 /C10-30烷基丙烯酸酯交联聚合物 Pemulen TR-2产品 0.1-0.7份、 Lubrizol Corporation公司丙烯酸酯 /C10-30烷基丙烯酸酯交联聚合物 Ultrez 20产品 0.1-0.7份 , 所述保湿剂包括苯氧乙醇 0.1-0.5份、 戊二醇和辛乙二醇 1: 1的二醇混合物 0.1-0.5 份。 [0028] A further technical solution of the present invention is: The viscosity reducing agent comprises 10-14 parts of Dow Coming Corporation polydimethylsiloxane and trisiloxane PMX-1184 product, Dow Coming Corporation polydimethyl Silicone PMX-200 product 1-5 parts; the emulsifier includes Shin-Etsu Chemical Corporation polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane KSG - 240 products 3-7 parts, Dow Corning Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-2233 product 0.05-0.3 parts; the thickener includes Lubrizol Corporation 0.1-0.7 parts of acrylate/C10-30 alkyl acrylate cross-linked polymer Pemulen TR-2, Lubrizol Corporation acrylate/C10-30 alkyl acrylate cross-linked polymer Ultrez 20 product 0.1-0.7 parts, The humectant comprises 0.1-0.5 parts of phenoxyethanol, 0.1-0.5 parts of a diol mixture of pentanediol and octylene glycol 1:1.

[0029] 本发明的进一步技术方案是: 所述增稠剂包括 Dow Coming Corporation公司十 甲基环五硅氧烷和聚二甲基硅氧烷聚合物 DC9045产品 8-13份、 Dow Corning Corporation公司聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷 DC9040产品 1-3份 、 氯化钠 0.3-0.7份; 所述铺展剂包括 Shin-Etsu Chemical Corporation公司环五聚二 甲基硅氧烷 KF-995产品 13-18份、 Dow Corning Corporation公司环五聚二甲基硅 氧烷 PMX-0245产品 0.1-3份; 所述保湿剂包括苯氧乙醇 0.1-0.7份、 戊二醇和辛乙 二醇 1: 1的二醇混合物 3-7份、 丙二醇 8-13份、 丁二醇 8-13份、 甘油 3-8份; 所述乳 化剂包括 Shin-Etsu Chemical Corporation公司聚二甲基硅氧院 /PEG-10/15交联聚合 物和十甲基环五硅氧烷 KSG-240产品 2-7份、 Dow Corning Corporation公司二异丁 基 PEG/PPG-10/7/聚二甲基硅氧烷共聚物 FZ-2233产品 0.1-0.3份。  [0029] A further technical solution of the present invention is: The thickener comprises 8-13 parts of Dow Coming Corporation's decamethylcyclopentasiloxane and polydimethylsiloxane polymer DC9045 product, Dow Corning Corporation Polydimethylsiloxane cross-linking copolymer and 1-5 parts of cyclopentamethylsiloxane DC9040 product, 0.3-0.7 parts of sodium chloride; the spreading agent includes ring-polydimethylene of Shin-Etsu Chemical Corporation 13-18 parts of the base silicone KF-995 product, 0.1-3 parts of the cyclopentadimethylsiloxane PMX-0245 product of Dow Corning Corporation; the humectant includes 0.1-0.7 parts of phenoxyethanol, 3-7 parts of a diol mixture of alcohol and octylene glycol 1:1, 8-13 parts of propylene glycol, 8-13 parts of butanediol, and 3-8 parts of glycerin; the emulsifier includes Shin-Etsu Chemical Corporation poly 2 2-7 parts of methyl silicone/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane KSG-240, Dow Corning Corporation diisobutyl PEG/PPG-10/7/poly The dimethyl siloxane copolymer FZ-2233 product is 0.1-0.3 parts.

发明的有益效果  Advantageous effects of the invention

有益效果  Beneficial effect

[0030] 本发明的有益效果是: 本方案中第一反应液可与皮肤紧密粘附,涂抹第二反应液 后聚硅氧烷成分在铂催化剂的作用下可交联形成坚固的网状结构, 形成的仿生 皮肤化妆品耐洗防水,具备正常皮肤的生物力学性能, 去除吋仅需直接撕幵即可 , 方便安全, 制备快捷。 本方案具备以下优势 : 1)现有的文献资料记载表明本发 明专利涉及的配方成分具备安全性和生物相容性,无致敏致炎; 2)粘度适宜,在皮肤 表面易涂抹均匀,易成膜; 3)生物力学性能佳, 如拉伸模量、 粘附性、 收缩性等 ; 4) 透气保湿性能佳, 耐洗防水, 可阻挡外界有害因素的侵害; 5) 本发明专 利方法制备的仿生皮肤表面平滑且厚度仅为 75微米, 添加的 NylonlO-12具备良好 的光学效果, 可使仿生皮肤与人体皮肤表面完美结合, 无明显的连接界线。 应 用本发明方法制备的仿生皮肤应用于人体皮肤后可使皮肤光滑、 富有弹性, 减 轻皱纹。 [0030] The beneficial effects of the present invention are: The first reaction liquid in the solution can be closely adhered to the skin, and after the second reaction liquid is applied, the silicone component can be crosslinked under the action of the platinum catalyst to form a strong network structure. The bionic skin cosmetics formed are washable and waterproof, and have the biomechanical properties of normal skin. The only need to directly remove the cockroaches is to remove the cockroaches, which is convenient and safe, and is quick to prepare. The program has the following advantages: 1) The existing literature records indicate that the formulation components involved in the invention have safety and biocompatibility, no sensitization and inflammation; 2) suitable viscosity, easy to spread evenly on the skin surface, easy Film formation; 3) good biomechanical properties, such as tensile modulus, adhesion, shrinkage, etc.; 4) good breathability and moisturizing properties, washable and waterproof, can block the harmful factors of the outside; 5) preparation of the patented method of the present invention The surface of the bionic skin is smooth and only 75 microns thick. The added NylonlO-12 has good optical effect, which can make the bionic skin perfectly combine with the human skin surface without obvious connecting lines. The bionic skin prepared by the method of the invention can be applied to human skin to make the skin smooth and elastic, and less Light wrinkles.

对附图的简要说明  Brief description of the drawing

附图说明  DRAWINGS

[0031] 在此处键入附图说明描述段落。  [0031] The description paragraphs are entered here by way of a drawing.

实施该发明的最佳实施例  BEST MODE FOR CARRYING OUT THE INVENTION

本发明的最佳实施方式  BEST MODE FOR CARRYING OUT THE INVENTION

[0032] 在此处键入本发明的最佳实施方式描述段落。 [0032] The paragraphs describing the best mode of the invention are entered here.

本发明的实施方式 Embodiments of the invention

[0033] 以下各实施例的说明是参考附加的图式, 用以例示本发明可用以实施的特定实 施例。 本发明所提到的方向用语, 例如 「上」 、 「下」 、 「前」 、 「后」 、 Γ 左」 、 「右」 、 「内」 、 「外」 、 「侧面」 等, 仅是参考附加图式的方向。 因 此, 使用的方向用语是用以说明及理解本发明, 而非用以限制本发明。  [0033] The following description of the various embodiments is provided by way of illustration The directional terms mentioned in the present invention, such as "upper", "lower", "before", "after", "left", "right", "inside", "outside", "side", etc., are only references Attach the direction of the drawing. Therefore, the directional terminology used is for the purpose of illustration and understanding of the invention.

[0034] 本发明首先提供了一种仿生皮肤, 所述仿生皮肤由基础反应物、 助剂和水在催 化剂的催化作用下发生乳液聚合形成交联网状结构而成; 其中所述基础反应物 占反应物总质量的 10-20%, 所述助剂占反应物总质量的 40-55%, 其余为水; 所 述基础反应物包括 47-60份乙烯基封端的聚二甲基硅氧烷、 20-29份的气相法白炭 黑和 17-36份含活性氢基的聚硅氧烷; 所述催化剂为 Karstedt铂催化剂, 所述催化 剂的含铂量为 1-5%; 所述助剂包括降低产品粘腻感的降粘剂、 增加产品乳化程 度的乳化剂、 增加皮肤表面湿度的保湿剂、 调节产品酸碱度的 pH调节剂、 增加 产品粘度的增稠剂、 改善产品铺张性能的铺展剂以及增强产品分散性和提高美 学效果的美化剂; 所述降粘剂包括聚二甲基硅氧烷和三硅氧烷、 聚二甲基硅氧 烷中的一种或两种; 所述乳化剂包括聚二甲基硅氧院 /PEG-10/15交联聚合物和十 甲基环五硅氧烷、 二异丁基 PEG/PPG- 10/7/聚二甲基硅氧烷共聚物中的一种或两 种; 所述保湿剂包括苯氧乙醇、 戊二醇和辛乙二醇 1:1的二醇混合物、 丙二醇、 丁二醇、 甘油中的一种或多种; 所述 pH调节剂为氢氧化钠; 所述增稠剂包括丙 烯酸酯 /C10-30烷基丙烯酸酯交联聚合物、 十甲基环五硅氧烷和聚二甲基硅氧烷 聚合物、 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷、 氯化钠中的一种或多 种; 所述铺展剂为环五聚二甲基硅氧烷; 所述美化剂为三异硬脂酸异丙氧钛盐 修饰的尼龙 12。 通过上述材料制备一种人造皮肤。 通过基础反应物形成人造皮 肤骨架, 通过加入助剂改变人造皮肤的性能。 [0034] The present invention firstly provides a biomimetic skin, which is formed by emulsion polymerization of a base reactant, an auxiliary agent and water under the catalytic action of a catalyst to form a crosslinked network structure; wherein the base reactant accounts for 10-20% of the total mass of the reactants, the adjuvant is 40-55% of the total mass of the reactants, the balance being water; the base reactant comprises 47-60 parts of vinyl terminated polydimethylsiloxane 20-29 parts of fumed silica and 17-36 parts of active hydrogen group-containing polysiloxane; the catalyst is a Karstedt platinum catalyst, and the catalyst has a platinum content of 1-5%; The agent includes a viscosity reducing agent for reducing the stickiness of the product, an emulsifier for increasing the degree of emulsification of the product, a moisturizing agent for increasing the surface moisture of the skin, a pH adjuster for adjusting the pH of the product, a thickener for increasing the viscosity of the product, and a spreading property for improving the product spreading property. And a beautifying agent for enhancing product dispersibility and improving aesthetic effects; the viscosity reducing agent comprising one or both of polydimethylsiloxane and trisiloxane, polydimethylsiloxane; Emulsifiers include polydimethylsiloxane/PE One or both of G-10/15 crosslinked polymer and decamethylcyclopentasiloxane, diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer; The humectant comprises a mixture of phenoxyethanol, pentanediol and octylene glycol 1:1, a propylene glycol, a butanediol, a glycerin; the pH adjuster is sodium hydroxide; Thickeners include acrylate/C10-30 alkyl acrylate crosspolymer, decamethylcyclopentasiloxane and polydimethylsiloxane a polymer, a polydimethylsiloxane crosslinked copolymer, and one or more of cyclopentamethylsiloxane and sodium chloride; the spreading agent is cyclopentadimethylsiloxane; The beautifying agent is nylon 12 modified with isopropoxytitanium triisostearate. An artificial skin is prepared from the above materials. The artificial skin skeleton is formed by the base reactant, and the properties of the artificial skin are changed by adding an adjuvant.

[0035] 本方案提供的人造皮肤安全可靠, 现有的文献资料记载表明本发明专利涉及的 配方成分具备安全性和生物相容性,无致敏致炎。  [0035] The artificial skin provided by the present solution is safe and reliable, and the existing literature records indicate that the formulation components of the present invention have safety and biocompatibility, and are not sensitized and inflammatory.

[0036] 需要指出的是, 本方案中提到的"聚二甲基硅氧烷和三硅氧烷"是指一种材料, 而不是 "聚二甲基硅氧烷"和"三硅氧烷"两种材料。 同样, 聚二甲基硅氧院 /PEG-1 0/15交联聚合物和十甲基环五硅氧烷、 十甲基环五硅氧烷和聚二甲基硅氧烷聚合 物、 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷也同样分别代指一种物质。  [0036] It should be noted that the "polydimethylsiloxane and trisiloxane" mentioned in the present scheme refers to a material instead of "polydimethylsiloxane" and "trisiloxane". Alkane "two materials. Similarly, polydimethylsiloxane/PEG-1 0/15 crosslinked polymer and decamethylcyclopentasiloxane, decamethylcyclopentasiloxane and polydimethylsiloxane polymer, poly The dimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane also refer to one substance, respectively.

[0037] 进一步的, 所述乙烯基封端的聚二甲基硅氧烷为 Andisil公司 VS200产品和 VS10 产品的混合物; 所述含活性氢基的聚硅氧烷为 Andisil公司 XL-11产品; 所述 Karst edt铂催化剂为 AB Specialty Silicones公司产品; 所述聚二甲基硅氧烷和三硅氧烷 为 Dow Corning Corporation公司 PMX-1184产品; 所述聚二甲基硅氧烷为 Dow Coming Corporation公司 PMX-200产品; 所述聚二甲基硅氧院 /PEG-10/15交联聚 合物和十甲基环五硅氧烷为 Shin-Etsu Chemical Corporation公司 KSG-240产品; 所 述二异丁基 PEG/PPG- 10/7/聚二甲基硅氧烷共聚物为 Dow Corning  [0037] Further, the vinyl terminated polydimethylsiloxane is a mixture of Andisil VS200 product and VS10 product; the active hydrogen group-containing polysiloxane is Andisil XL-11 product; The Karst edt platinum catalyst is a product of AB Specialty Silicones; the polydimethylsiloxane and trisiloxane are products of Dow Corning Corporation PMX-1184; the polydimethylsiloxane is Dow Coming Corporation PMX-200 product; the polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane are products of Shin-Etsu Chemical Corporation KSG-240; PEG/PPG-10/7/polydimethylsiloxane copolymer for Dow Corning

Corporation公司 FZ-2233产品; 丙烯酸酯 /C 10-30烷基丙烯酸酯交联聚合物为 Lubri zol Corporation公司 Pemulen TR-2产品和 Ultrez 20产品的混合物; 所述十甲基环五 硅氧烷和聚二甲基硅氧烷聚合物为 Dow Corning Corporation公司 DC9045产品; 所 述聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷为 Dow Corning  Corporation FZ-2233 product; acrylate/C 10-30 alkyl acrylate crosspolymer is a mixture of Lubri zol Corporation Pemulen TR-2 product and Ultrez 20 product; the decamethylcyclopentasiloxane and The polydimethylsiloxane polymer is a Dow Corning Corporation DC9045 product; the polydimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane are Dow Corning

Corporation公司 DC9040产品; 所述环五聚二甲基硅氧烷为 Dow Corning  Corporation DC9040 product; the cyclopentasiloxane is Dow Corning

Corporation公司 PMX-0245产品和 Shin-Etsu Chemical Corporation公司 KF-995产品 的混合物; 所述三异硬脂酸异丙氧钛盐修饰的尼龙 12为 Kobo Products公司 NylonlO-12产品。  A mixture of PMX-0245 product of Corporation and KF-995 product of Shin-Etsu Chemical Corporation; the nylon 12 modified with isopropoxysulphate is Kobo Products NylonlO-12 product.

[0038] 本发明还公幵了一种仿生皮肤的制造方法。  [0038] The present invention also discloses a method of producing bionic skin.

[0039] 该方法包括以下步骤,  [0039] The method includes the following steps,

[0040] 步骤 A: 制备第一反应液; 所述第一反应液包括均匀混合的基础反应物、 水 和助剂; 其中所述基础反应物占第一反应液总质量的 25-36%, 所述助剂占第一 反应液总质量的 15-25%, 其余为水; 所述基础反应物包括 47-60份乙烯基封端的 聚二甲基硅氧烷、 20-29份的气相法白炭黑和 17-36份含活性氢基的聚硅氧烷; [0041] 所述步骤 A包括以下分步骤, [0040] Step A: preparing a first reaction liquid; the first reaction liquid includes a homogeneously mixed base reactant, water And an auxiliary agent; wherein the basic reactant accounts for 25-36% of the total mass of the first reaction liquid, the auxiliary agent accounts for 15-25% of the total mass of the first reaction liquid, and the rest is water; the basic reactant includes 47-60 parts of vinyl-terminated polydimethylsiloxane, 20-29 parts of fumed silica, and 17-36 parts of active hydrogen-containing polysiloxane; [0041] Step A includes the following Step by step,

[0042] 步骤 A1 : 制备主反应溶液; 所述主反应溶液由基础反应物、 降低产品粘腻感 的降粘剂和增加产品乳化程度的乳化剂均匀混合后获得; 所述基础反应物中包 含包括 7-10份 Andisil公司乙烯基封端的聚二甲基硅氧烷 VS  [0042] Step A1: preparing a main reaction solution; the main reaction solution is obtained by uniformly mixing a base reactant, a viscosity reducer for reducing the stickiness of the product, and an emulsifier for increasing the degree of emulsification of the product; Includes 7-10 parts of Andisil's vinyl terminated polydimethylsiloxane VS

200产品、 40-50份 Andisil公司乙烯基封端的聚二甲基硅氧烷 VS 10产品、 20-29份 的气相法白炭黑和 17-36份含活性氢基的聚硅氧烷;  200 products, 40-50 parts of Andisil's vinyl terminated polydimethylsiloxane VS 10 product, 20-29 parts of fumed silica and 17-36 parts of active hydrogen-containing polysiloxane;

[0043] 步骤 A2: 制备稀释溶液: 所述稀释溶液由增稠剂、 增加皮肤表面湿度的保湿 剂和水均匀混合后获得; [0043] Step A2: preparing a diluted solution: the diluted solution is obtained by uniformly mixing a thickener, a moisturizer that increases the surface moisture of the skin, and water;

[0044] 步骤 A3: 制备第一反应液; 所述第一反应液系将所述稀释溶液缓慢添加到所 述主反应溶液中至形成白色奶油状乳液后形成。 [0044] Step A3: preparing a first reaction liquid; the first reaction liquid is formed by slowly adding the diluted solution to the main reaction solution until a white creamy emulsion is formed.

[0045] 步骤 A4: 加入 pH调节剂并调节所述第一反应液至 pH值为 5.5-6.6。 本方案可以 通过浓度为 10N的氢氧化钠溶液对 pH值进行调节。 Step A4: A pH adjuster is added and the first reaction solution is adjusted to a pH of 5.5-6.6. In this scheme, the pH can be adjusted by a 10N sodium hydroxide solution.

[0046] 其中, 所述降粘剂包括 Dow Corning Corporation公司聚二甲基硅氧烷和三硅 氧烷 PMX- 1184产品 10- 14份、 Dow Coming [0046] wherein the viscosity reducing agent comprises Dow Corning Corporation polydimethylsiloxane and trisiloxane PMX-1184 product 10-14 parts, Dow Coming

Corporation公司聚二甲基硅氧烷 PMX-200产品 1-5份; 所述乳化剂包括 Shin-Etsu Chemical Corporation公司聚二甲基硅氧烷 /PEG-10/15交联聚合物和十甲基环五硅 氧烷 KSG-240产品 3-7份、 Dow Corning Corporation公司二异丁基 PEG/PPG- 10/7/ 聚二甲基硅氧烷共聚物 FZ-2233产品 0.05-0.3份; 所述增稠剂包括 Lubrizol Corporation公司丙烯酸酯 /C10-30烷基丙烯酸酯交联聚合物 Pemulen  Corporation Corporation Polydimethylsiloxane PMX-200 product 1-5 parts; the emulsifier includes Shin-Etsu Chemical Corporation polydimethylsiloxane / PEG-10 / 15 cross-linked polymer and decamethyl 3-7 parts of cyclopentasiloxane KSG-240 product, Dow Corning Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-2233 product 0.05-0.3 parts; Thickeners include Lubrizol Corporation acrylate/C10-30 alkyl acrylate crosspolymer PEmulen

TR-2产品 0.1-0.7份、 Lubrizol Corporation公司丙烯酸酯 /C10-30烷基丙烯酸酯交联 聚合物 UltreZ 20产品 0.1-0.7份, 所述保湿剂包括苯氧乙醇 0.1-0.5份、 戊二醇和辛 乙二醇 1: 1的二醇混合物 0.1-0.5份 0.1-0.7 parts of TR-2 product, 0.1-0.7 parts of Lubrizol Corporation acrylate/C10-30 alkyl acrylate cross-linked polymer Ultre Z 20 product, the humectant includes phenoxyethanol 0.1-0.5 parts, pentylene 0.1-0.5 parts of a mixture of alcohol and octylene glycol 1:1

[0047] 步骤 B : 制备第二反应液; 所述第二反应液包括均匀混合的催化剂、 水和助 齐 1J ; 其中催化剂质量占所述第二反应液总质量的 0.5-3%, 所述助剂占所述第二反 应液总质量的 60-80%, 其余为水; 所述催化剂为 Karstedt铂催化剂, 所述催化剂 的含铂量为 1-5% ; [0047] Step B: preparing a second reaction liquid; the second reaction liquid comprises a uniformly mixed catalyst, water and a solvent; wherein the catalyst mass accounts for 0.5-3% of the total mass of the second reaction liquid, The auxiliary agent accounts for 60-80% of the total mass of the second reaction liquid, and the balance is water; the catalyst is a Karstedt platinum catalyst, the catalyst The platinum content is 1-5%;

[0048] 所述步骤 B包括以下分步骤, [0048] The step B includes the following sub-steps,

[0049] 步骤 B 1 : 制备增稠溶液, 所述增稠溶液由增加产品粘度的增稠剂、 改善产品 铺张性能的铺展剂以及增加产品乳化程度的乳化剂均匀混合后形成;  [0049] Step B1: preparing a thickening solution formed by uniformly mixing a thickener which increases the viscosity of the product, a spreading agent for improving the spreading property of the product, and an emulsifier which increases the degree of emulsification of the product;

[0050] 步骤 B2: 制备保湿溶液, 所述保湿溶液由水和增加皮肤表面湿度的保湿剂组 成;  [0050] Step B2: preparing a moisturizing solution composed of water and a moisturizing agent that increases the surface moisture of the skin;

[0051] 步骤 B3:制备第二反应液; 所述第二反应液系将所述保湿溶液缓慢滴加到所述 增稠溶液中至形成清澈乳液后再加入催化剂获得。  [0051] Step B3: preparing a second reaction liquid; the second reaction liquid is obtained by slowly adding the moisturizing solution to the thickening solution until a clear emulsion is formed, and then adding a catalyst.

[0052] 所述步骤 B3中加入所述催化剂之前加入 3-7份增强产品分散性和提高美学效果 的美化剂; 所述美化剂为三异硬脂酸异丙氧钛盐修饰的尼龙。  [0052] 3-7 parts of a beautifying agent for enhancing product dispersibility and improving aesthetic effect are added before the catalyst is added in the step B3; the beautifying agent is nylon modified with isopropoxytitanate.

[0053] 所述增稠剂包括 Dow Corning Corporation公司十甲基环五硅氧烷和聚二甲基 硅氧烷聚合物 DC9045产品 8-13份、 Dow Corning Corporation公司聚二甲基硅氧烷 交联共聚物和环五甲基硅氧烷 DC9040产品 1-3份、 氯化钠 0.3-0.7份; 所述铺展剂 包括 Shin-Etsu Chemical Corporation公司环五聚二甲基硅氧烷 KF-995产品 13- 18份 、 Dow Corning Corporation公司环五聚二甲基硅氧烷 PMX-0245产品 0.1-3份; 所 述保湿剂包括苯氧乙醇 0.1-0.7份、 戊二醇和辛乙二醇 1: 1的二醇混合物 3-7份、 丙 二醇 8-13份、 丁二醇 8-13份、 甘油 3-8份; 所述乳化剂包括 Shin-Etsu Chemical Corporation公司聚二甲基硅氧院 /PEG-10/15交联聚合物和十甲基环五硅氧烷 KSG- 240产品 2-7份、 Dow Corning Corporation公司二异丁基 PEG/PPG- 10/7/聚二甲基硅 氧烷共聚物 FZ-2233产品 0.1-0.3份。  [0053] The thickener includes 8-13 parts of Dow Corning Corporation's decamethylcyclopentasiloxane and polydimethylsiloxane polymer DC9045 product, Dow Corning Corporation polydimethylsiloxane 1-3 parts of a copolymer and a cyclopentamethylsiloxane DC9040 product, and 0.3-0.7 parts of sodium chloride; the spreading agent includes a cyclopentadimethylsiloxane KF-995 product of Shin-Etsu Chemical Corporation 13- 18 parts, Dow Corning Corporation, 5-penta-dimethylsiloxane PMX-0245 product 0.1-3 parts; the humectant includes phenoxyethanol 0.1-0.7 parts, pentanediol and octylene glycol 1: 1 3-7 parts of the diol mixture, 8-13 parts of propylene glycol, 8-13 parts of butanediol, and 3-8 parts of glycerin; the emulsifier includes Shin-Etsu Chemical Corporation polydimethylsiloxane/PEG- 2/7 parts of 10/15 crosslinked polymer and decamethylcyclopentasiloxane KSG-240, Dow Corning Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-2233 product 0.1-0.3 parts.

[0054] 步骤 C: 将所述第一反应液涂抹于皮肤上;  [0054] Step C: applying the first reaction solution to the skin;

[0055] 步骤 D: 将所述第二反应液涂抹于步骤 C中涂抹了所述第一反应液的区域上, 反应形成人造皮肤; 所述第二反应液的涂抹质量为所述第一反应液的 1-2倍。  [0055] Step D: applying the second reaction solution to the area where the first reaction liquid is applied in the step C, and reacting to form artificial skin; the application quality of the second reaction liquid is the first reaction 1-2 times the liquid.

[0056] 下面给出按照上述方法制备人造皮肤的具体实施例。 Specific examples of preparing artificial skin according to the above method are given below.

[0057] 具体实施例 1 : DETAILED DESCRIPTION OF THE INVENTION 1:

[0058] 1 . 乳液 1 [0058] 1. Emulsion 1

[0059] a.在混合器 1中, 将 31.0%基础反应物、 12.0<¾PMX-1184 (聚二甲基硅氧烷和三 硅氧烷)、 2.0% PMX-200(聚二甲基硅氧烷)、 5.0%KSG-240 (聚二甲基硅氧烷 /PEG-10/15交联聚 合物和十甲基环五硅氧烷) 、 0.1<¾FZ-2233 (二异丁基 PEG/PPG-10/7/聚二甲基硅 氧烷共聚物) 混合均匀。 [0059] a in the mixer 1, 31.0% of the base reactant, 12.0 <3⁄4PMX-1184 (polydimethylsiloxane and trisiloxane), 2.0% PMX-200 (polydimethylsiloxane), 5.0% KSG-240 (polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane), 0.1<3⁄4FZ -2233 (diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer) Mix well.

[0060] 其中基础反应物中有 25%为气相法白炭黑, 气相法白炭黑可增强产品的机械韧 性和粘度。 剩余 75%质量中包含 11.0%的乙烯基封端的聚二甲基硅氧烷(Andisil, VS 200)、 60.0%乙烯基封端的聚二甲基硅氧烷(Andisil, VS10)和 29.0%含活性氢 基的聚硅氧烷 (Andisil, XL-11)。  [0060] wherein 25% of the base reactant is fumed silica, and the fumed silica enhances the mechanical toughness and viscosity of the product. The remaining 75% by mass contained 11.0% vinyl terminated polydimethylsiloxane (Andisil, VS 200), 60.0% vinyl terminated polydimethylsiloxane (Andisil, VS10) and 29.0% active Hydrogen-based polysiloxane (Andisil, XL-11).

[0061] b.在混合器 2中, 将 48.4%水、 0.4<¾Pemulen TR-2 (丙烯酸酯 /C10-30烷基丙烯酸 酯交联聚合物) 、 0.4<¾Ultrez 20 (丙烯酸酯 /C10-30烷基丙烯酸酯交联聚合物) 、 0.2%苯氧乙醇、 0.3%二醇混合物 (戊二醇和辛乙二醇 ,1:1)混合均匀。 [0061] b. In the mixer 2, 48.4% water, 0.4 <¾Pemulen TR-2 (acrylates / C10-30 alkyl acrylate cross-linked polymer), 0.4 <¾Ult rez 20 (acrylates / C10- 30 alkyl acrylate crosslinked polymer), 0.2% phenoxyethanol, 0.3% diol mixture (pentanediol and octylene glycol, 1:1) were uniformly mixed.

[0062] c.将 b步骤获得的混合物缓慢添加到 a步骤获得的混合物中, 直至形成白色奶油 状乳液, 加入 0.2% 10N氢氧化钠溶液,调整其 pH值至 5.5-6.5。  c. The mixture obtained in step b was slowly added to the mixture obtained in the step a until a white creamy emulsion was formed, and 0.2% 10N sodium hydroxide solution was added thereto, and the pH was adjusted to 5.5 to 6.5.

[0063] 2.乳液 2  2. Emulsion 2

[0064] d.在混合器 3中, 将 10.0% DC9045 (十甲基环五硅氧烷和聚二甲基硅氧烷聚合 物) 、 2.0%  [0064] d. In Mixer 3, 10.0% DC9045 (decamethylcyclopentasiloxane and polydimethylsiloxane polymer), 2.0%

DC9040 (聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷) 、 5.0<¾KSG-240 (聚 二甲基硅氧院 /PEG-10/15交联聚合物和十甲基环五硅氧烷) 、 0.2%FZ-2233 (二 异丁基 PEG/PPG-10/7/聚二甲基硅氧烷共聚物) 、 15.0%KF-995 (环五聚二甲基硅 氧烷)、 1.0%PMX-0245(环五聚二甲基硅氧烷)、 0.5%氯化钠、 5.0%甘油混合均匀  DC9040 (polydimethylsiloxane cross-linked copolymer and cyclopentamethylsiloxane), 5.0<3⁄4KSG-240 (polydimethylsiloxane/PEG-10/15 cross-linked polymer and decamethyl Cyclopentasiloxane), 0.2% FZ-2233 (diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer), 15.0% KF-995 (cyclopentadimethylsiloxane) Alkane), 1.0% PMX-0245 (cyclopentadimethylsiloxane), 0.5% sodium chloride, 5.0% glycerol mixed evenly

[0065] e.在混合器 4中, 将 30.0%水、 0.3%苯氧乙醇、 5.0%二醇混合物 (戊二醇和辛乙 二醇, 1:1)、 10.0%丙二醇、 10.0%丁二醇混合均匀。 [0065] e in the mixer 4, 30.0% water, 0.3% phenoxyethanol, 5.0% diol mixture (pentylene glycol and octylene glycol, 1:1), 10.0% propylene glycol, 10.0% butanediol well mixed.

[0066] f.将 e步骤获得的混合物缓慢滴入 d步骤获得的混合物直至形成清澈的乳液, 再 将 5.0<¾NylonlO-12缓慢加入该乳液中混合均匀, 最后添加 1.0% Karstedt铂催化剂 溶液 (含 2.0%铂)并混合均匀。 [0066] f The mixture obtained in step e is slowly dropped into the mixture obtained in step d until a clear emulsion is formed, then 5.0 < 3⁄4 NylonlO-12 is slowly added to the emulsion to be homogeneously mixed, and finally 1.0% Karstedt platinum catalyst solution is added (including 2.0% platinum) and mix well.

[0067] 使用吋乳液 1和乳液 2的用量比例为 2:3, 先涂抹乳液 1, 再涂抹乳液 2, 乳液 1可 与皮肤紧密粘附,涂抹乳液 2后聚硅氧烷成分在铂催化剂的作用下可交联形成坚固 的网状结构, 形成的仿生皮肤化妆品耐洗防水,具备正常皮肤的生物力学性能。 去除吋仅需撕幵即可。 [0067] The ratio of the emulsion 1 and the emulsion 2 is 2:3, the emulsion 1 is applied first, and then the emulsion 2 is applied. The emulsion 1 can be closely adhered to the skin, and the silicone component is coated with the platinum catalyst after the emulsion 2 is applied. Under the action, it can be cross-linked to form a firm network structure, and the formed bionic skin cosmetics are washable and waterproof, and have the biomechanical properties of normal skin. To remove the crucible, just tear it.

[0068] 经过检测, 本具体实施例获得的人造皮肤的力学性能如下。  [0068] After testing, the mechanical properties of the artificial skin obtained in the specific example are as follows.

[0069] 拉伸模量为 0.45MPa, 断裂应变为 800%, 粘附强度为 78N mm -1The tensile modulus was 0.45 MPa, the strain at break was 800%, and the adhesion strength was 78 N mm -1 .

[0070] 拉伸实验表明正常皮肤在 40%应变下的拉伸模量是 0.5-1.95MPa,本发明专利方 法制备的仿生皮肤化妆品在拉伸模量为 0.5 MPa吋断裂应变达 240%。 所以本方案 提供的人造皮肤具有很好的弹性。  [0070] The tensile test showed that the tensile modulus of normal skin at 40% strain was 0.5-1.95 MPa, and the bionic skin cosmetic prepared by the method of the present invention had a tensile modulus of 0.5 MPa and a strain at break of 240%. Therefore, the artificial skin provided by this program has good elasticity.

[0071] 将本发明专利方法制备的仿生皮肤化妆品应用于前臂 24h后, 皮肤回缩吋间相 比应用前降低 26.7% (应用前和应用后分别为 750ms、 550ms) 。 说明皮肤弹性 显著改善。 [0071] After applying the bionic skin cosmetic prepared by the patented method of the present invention to the forearm for 24 hours, the skin retraction intercondylar phase was reduced by 26.7% compared with before application (750 ms, 550 ms before and after application). This indicates a significant improvement in skin elasticity.

[0072] 经皮水分流失 (TEWL) 检测试验显示, 本发明专利方法制备的仿生皮肤化妆 品应用 24h后 TEWL下降 20% (应用前和应用 24h后分别为 4.0g/m ¾、 3.2g/m ¾) [0072] The transepidermal water loss (TEWL) test showed that the TEWL of the bionic skin cosmetic prepared by the method of the present invention decreased by 20% after 24 hours of application (4.0 g/m 3⁄4, 3.2 g/m 3⁄4 before and after application for 24 hours). )

。 说明本方案提供的人造皮肤能够有效地保持皮肤水分, 避免水分流失。 . Explain that the artificial skin provided by this program can effectively maintain skin moisture and avoid water loss.

[0073] 综上所述, 本方案提供的人造皮肤具备以下优势 :1)现有的文献资料记载表明本 发明专利涉及的配方成分具备安全性和生物相容性,无致敏致炎; 2)粘度适宜,在皮 肤表面易涂抹均匀,易成膜; 3)生物力学性能佳, 如拉伸模量、 粘附性、 收缩性 等; 4) 透气保湿性能佳, 耐洗防水, 可阻挡外界有害因素的侵害; 5) 本发明 专利方法制备的仿生皮肤表面平滑且厚度仅为 75微米, 添加的 NylonlO-12具备良 好的光学效果, 可使仿生皮肤与人体皮肤表面完美结合, 无明显的连接界线。 应用本发明方法制备的仿生皮肤应用于人体皮肤后可使皮肤光滑、 富有弹性, 减轻皱纹。 [0073] In summary, the artificial skin provided by the present solution has the following advantages: 1) The existing literature records indicate that the formulation components of the present invention have safety and biocompatibility, and are not sensitized and inflammatory; 2 Appropriate viscosity, easy to spread on the skin surface, easy to form a film; 3) good biomechanical properties, such as tensile modulus, adhesion, shrinkage, etc.; 4) good breathability and moisturizing properties, washable and waterproof, can block the outside world Invasion of harmful factors; 5) The bionic skin prepared by the patented method of the invention has a smooth surface and a thickness of only 75 μm, and the added Nylonl O-12 has a good optical effect, so that the bionic skin can be perfectly combined with the surface of the human skin without obvious connection. Boundary. The bionic skin prepared by the method of the invention can be applied to human skin to make the skin smooth, elastic and wrinkle-reducing.

[0074] 以上所述仅为本发明的较佳实施例而已, 并不用以限制本发明, 凡在本发明的 精神和原则之内所作的任何修改、 等同替换和改进等, 均应包含在本发明的保 护范围之内。  The above is only the preferred embodiment of the present invention, and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the present invention. Within the scope of protection of the invention.

工业实用性  Industrial applicability

[0075] 在此处键入工业实用性描述段落。 [0075] Enter the paragraph of industrial applicability description here.

序列表自由内容  Sequence table free content

[0076] 在此处键入序列表自由内容描述段落。 [0076] Type the sequence table free content description paragraph here.

Claims

权利要求书 Claim [权利要求 1] 一种仿生皮肤, 其特征在于: 所述仿生皮肤由基础反应物、 助剂和水 在催化剂的催化作用下发生乳液聚合形成交联网状结构而成; 其中所 述基础反应物占反应物总质量的 10-20%, 所述助剂占反应物总质量 的 40-55%, 其余为水; 所述基础反应物包括 47-60份乙烯基封端的聚 二甲基硅氧烷、 20-29份的气相法白炭黑和 17-36份含活性氢基的聚硅 氧烷; 所述催化剂为 Karstedt铂催化剂, 所述催化剂的含铂量为 1-5% ; 所述助剂包括降低产品粘腻感的降粘剂、 增加产品乳化程度的乳化 齐 ij、 增加皮肤表面湿度的保湿剂、 调节产品酸碱度的 PH调节剂、 增 加产品粘度的增稠剂、 改善产品铺张性能的铺展剂以及增强产品分散 性和提高美学效果的美化剂; 所述降粘剂包括聚二甲基硅氧烷和三硅 氧烷、 聚二甲基硅氧烷中的一种或两种; 所述乳化剂包括聚二甲基硅 氧院 /PEG-10/15交联聚合物和十甲基环五硅氧烷、 二异丁基 PEG/PPG -10/7/聚二甲基硅氧烷共聚物中的一种或两种; 所述保湿剂包括苯氧 乙醇、 戊二醇和辛乙二醇 1: 1的二醇混合物、 丙二醇、 丁二醇、 甘油 中的一种或多种; 所述 PH调节剂为氢氧化钠; 所述增稠剂包括丙烯 酸酯 /C10-30烷基丙烯酸酯交联聚合物、 十甲基环五硅氧烷和聚二甲 基硅氧烷聚合物、 聚二甲基硅氧烷交联共聚物和环五甲基硅氧烷、 氯 化钠中的一种或多种; 所述铺展剂为环五聚二甲基硅氧烷; 所述美化 剂为三异硬脂酸异丙氧钛盐修饰的尼龙 12。 [Claim 1] A bionic skin, characterized in that: the bionic skin is formed by emulsion polymerization of a base reactant, an auxiliary agent and water under the catalysis of a catalyst to form a crosslinked network structure; wherein the base reactant 10-20% of the total mass of the reactants, the auxiliary agent accounts for 40-55% of the total mass of the reactants, and the balance is water; the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane Alkane, 20-29 parts of fumed silica and 17-36 parts of active hydrogen group-containing polysiloxane; the catalyst is a Karstedt platinum catalyst, and the catalyst has a platinum content of 1-5%; Auxiliaries include viscosity reducers that reduce the stickiness of the product, emulsions that increase the degree of emulsification of the product, moisturizers that increase the moisture level of the skin, P H conditioners that adjust the pH of the product, thickeners that increase the viscosity of the product, and improved product spreads. a performance spreading agent and a beautifying agent for enhancing product dispersibility and improving aesthetic effects; the viscosity reducing agent comprises one or both of polydimethylsiloxane and trisiloxane, polydimethylsiloxane The emulsifier includes polydimethyl Oxygen/PEG-10/15 crosslinked polymer and one or both of decamethylcyclopentasiloxane, diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer The humectant includes phenoxyethanol, a diol mixture of pentanediol and octylene glycol 1: 1, one or more of propylene glycol, butanediol, and glycerin; and the P H regulator is sodium hydroxide The thickener includes an acrylate/C10-30 alkyl acrylate crosspolymer, decamethylcyclopentasiloxane and a polydimethylsiloxane polymer, and a polydimethylsiloxane crosslink. a copolymer and one or more of cyclopentamethylsiloxane and sodium chloride; the spreading agent is cyclopentadimethylsiloxane; and the beautifying agent is triisostearate isopropoxy Titanium salt modified nylon 12. [权利要求 2] 根据权利要求 1所述的仿生皮肤, 其特征在于, 所述乙烯基封端的聚 二甲基硅氧烷为 Andisil公司 VS200产品和 VS 10产品的混合物; 所述含 活性氢基的聚硅氧烷为 Andisil公司 XL-11产品; 所述 Karstedt铂催化剂 为 AB Specialty Silicones公司产品; 所述聚二甲基硅氧烷和三硅氧烷 为 Dow Corning Corporation公司 PMX-1184产品; 所述聚二甲基硅氧烷 为 Dow Corning [Claim 2] The bionic skin according to claim 1, wherein the vinyl-terminated polydimethylsiloxane is a mixture of an Andisil VS200 product and a VS10 product; the active hydrogen-containing group The polysiloxane is the Andisil XL-11 product; the Karstedt platinum catalyst is a product of AB Specialty Silicones; the polydimethylsiloxane and trisiloxane are Dow Corning Corporation PMX-1184; Polydimethylsiloxane is Dow Corning Corporation公司 PMX-200产品; 所述聚二甲基硅氧院 /PEG-10/15交联 聚合物和十甲基环五硅氧烷为 Shin-Etsu Chemical Corporation公司 KSG-240产品; 所述二异丁基 PEG/PPG- 10/7/聚二甲基 硅氧烷共聚物为 Dow Corning Corporation PMX-200 product; the polydimethylsiloxane/PEG-10/15 crosslinked polymer and decamethylcyclopentasiloxane are Shin-Etsu Chemical Corporation KSG-240 product; the diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer is Dow Corning Corporation公司 FZ-2233产品; 丙烯酸酯 /C10-30烷基丙烯酸酯交联聚 合物为 Lubrizol Corporation公司 Pemulen TR-2产品和 Ultrez 20产品的 混合物; 所述十甲基环五硅氧烷和聚二甲基硅氧烷聚合物为 Dow Corning Corporation公司 DC9045产品; 所述聚二甲基硅氧烷交联共聚 物和环五甲基硅氧烷为 Dow Corning Corporation公司 DC9040产品; 所 述环五聚二甲基硅氧烷为 Dow Corning Corporation公司 PMX-0245产品 和 Shin-Etsu Chemical Corporation公司 KF-995产品的混合物; 所述三 异硬脂酸异丙氧钛盐修饰的尼龙 12为 Kobo Products公司 NylonlO- 12产 p  Corporation FZ-2233 product; acrylate/C10-30 alkyl acrylate crosspolymer is a mixture of Lubrizol Corporation Pemulen TR-2 product and Ultrez 20 product; the decamethylcyclopentasiloxane and poly 2 The methyl siloxane polymer is Dow Corning Corporation DC9045 product; the polydimethylsiloxane crosslinked copolymer and cyclopentamethyl siloxane are Dow Corning Corporation DC9040 product; The methyl siloxane is a mixture of Dow Corning Corporation PMX-0245 product and Shin-Etsu Chemical Corporation KF-995 product; the triisostearate isopropoxide modified nylon 12 is Kobo Products NylonlO- 12 production p [权利要求 3] —种仿生皮肤的制备方法, 其特征在于, 包括以下步骤, [Claim 3] A method for preparing a bionic skin, comprising the following steps, 步骤 Α: 制备第一反应液; 所述第一反应液包括均匀混合的基础 反应物、 水和助剂; 其中所述基础反应物占第一反应液总质量的 25-3 6% , 所述助剂占第一反应液总质量的 15-25%, 其余为水; 所述基础 反应物包括 47-60份乙烯基封端的聚二甲基硅氧烷、 20-29份的气相法 白炭黑和 17-36份含活性氢基的聚硅氧烷;  Step Α: preparing a first reaction liquid; the first reaction liquid comprises a homogeneously mixed base reactant, water and an auxiliary agent; wherein the basic reactant accounts for 25-3 6% of the total mass of the first reaction liquid, The auxiliary agent accounts for 15-25% of the total mass of the first reaction liquid, and the balance is water; the base reactant comprises 47-60 parts of vinyl-terminated polydimethylsiloxane and 20-29 parts of fumed white carbon Black and 17-36 parts of active hydrogen group-containing polysiloxane; 步骤 Β : 制备第二反应液; 所述第二反应液包括均匀混合的催化 齐 1J、 水和助剂; 其中催化剂质量占所述第二反应液总质量的 0.5-3%, 所述助剂占所述第二反应液总质量的 60-80%, 其余为水; 所述催化 齐 1J为 Karstedt铂催化剂, 所述催化剂的含铂量为 1-5%  Step Β: preparing a second reaction liquid; the second reaction liquid comprises a uniformly mixed catalyst, water and an auxiliary agent; wherein the catalyst mass accounts for 0.5-3% of the total mass of the second reaction liquid, the auxiliary agent Accounting for 60-80% of the total mass of the second reaction liquid, the balance being water; the catalyst Qi 1J is a Karstedt platinum catalyst, and the platinum content of the catalyst is 1-5% 步骤 C: 将所述第一反应液涂抹于皮肤上;  Step C: applying the first reaction solution to the skin; 步骤 D : 将所述第二反应液涂抹于步骤 C中涂抹了所述第一反应 液的区域上, 反应形成人造皮肤; 所述第二反应液的涂抹质量为所述 第一反应液的 1-2倍。  Step D: applying the second reaction solution to the area where the first reaction liquid is applied in the step C, and reacting to form artificial skin; the application quality of the second reaction liquid is 1 of the first reaction liquid -2 times. [权利要求 4] 根据权利要求 3所述的仿生皮肤的制备方法, 其特征在于: 所述步骤  [Claim 4] The method for preparing bionic skin according to claim 3, wherein: the step A包括以下分步骤,  A includes the following substeps, 步骤 A1 : 制备主反应溶液; 所述主反应溶液由基础反应物、 降低 产品粘腻感的降粘剂和增加产品乳化程度的乳化剂均匀混合后获得; 所述基础反应物中包含包括 7-10份 Andisil公司乙烯基封端的聚二甲基 硅氧烷 VS 200产品、 40-50份 Andisil公司乙烯基封端的聚二甲基硅氧 烷 VS 10产品、 20-29份的气相法白炭黑和 17-36份含活性氢基的聚硅 氧烷; Step A1: preparing a main reaction solution; the main reaction solution is reduced by a base reactant The viscosity-reducing agent of the product is obtained by uniformly mixing the emulsifier which increases the degree of emulsification of the product; the base reactant comprises 7-10 parts of the vinyl-terminated polydimethylsiloxane VS 200 product of Andisil Company, 40-50 parts of Andisil's vinyl terminated polydimethylsiloxane VS 10 product, 20-29 parts of fumed silica and 17-36 parts of active hydrogen group-containing polysiloxane; 步骤 A2: 制备稀释溶液: 所述稀释溶液由增稠剂、 增加皮肤表面 湿度的保湿剂和水均匀混合后获得;  Step A2: preparing a diluted solution: the diluted solution is obtained by uniformly mixing a thickener, a moisturizer for increasing the surface moisture of the skin, and water; 步骤 A3: 制备第一反应液; 所述第一反应液系将所述稀释溶液缓 慢添加到所述主反应溶液中至形成白色奶油状乳液后形成。  Step A3: preparing a first reaction liquid; the first reaction liquid is formed by slowly adding the diluted solution to the main reaction solution until a white creamy emulsion is formed. [权利要求 5] 根据权利要求 4所述的仿生皮肤的制备方法, 其特征在于: 所述步骤 [Claim 5] The method for preparing bionic skin according to claim 4, wherein: the step A还包括分步骤 A4: 加入 pH调节剂并调节所述第一反应液至 pH值为 5 .5-6.6。  A also includes substep A4: adding a pH adjuster and adjusting the first reaction solution to a pH of 5. 5-6.6. [权利要求 6] 根据权利要求 3-5中任一所述的仿生皮肤的制备方法, 其特征在于: 所述步骤 B包括以下分步骤,  [Claim 6] The method for preparing bionic skin according to any one of claims 3-5, wherein: the step B comprises the following sub-steps, 步骤 B1 : 制备增稠溶液, 所述增稠溶液由增加产品粘度的增稠剂 、 改善产品铺张性能的铺展剂以及增加产品乳化程度的乳化剂均匀混 合后形成;  Step B1: preparing a thickening solution which is formed by uniformly adding a thickener which increases the viscosity of the product, a spreading agent which improves the spreading property of the product, and an emulsifier which increases the degree of emulsification of the product; 步骤 B2: 制备保湿溶液, 所述保湿溶液由水和增加皮肤表面湿度 的保湿剂组成;  Step B2: preparing a moisturizing solution consisting of water and a moisturizer for increasing the surface moisture of the skin; 步骤 B3:制备第二反应液; 所述第二反应液系将所述保湿溶液缓 慢滴加到所述增稠溶液中至形成清澈乳液后再加入催化剂获得。  Step B3: preparing a second reaction liquid; the second reaction liquid is obtained by slowly adding the moisturizing solution to the thickening solution until a clear emulsion is formed, and then adding a catalyst. [权利要求 7] 根据权利要求 6所述的仿生皮肤的制备方法, 其特征在于: 所述步骤  [Claim 7] The method for preparing bionic skin according to claim 6, wherein: the step B3中加入所述催化剂之前加入 3-7份增强产品分散性和提高美学效果 的美化剂; 所述美化剂为三异硬脂酸异丙氧钛盐修饰的尼龙。  Before adding the catalyst to B3, 3-7 parts of a beautifying agent for enhancing product dispersibility and improving aesthetic effect are added; the beautifying agent is nylon modified with isopropoxytitanate. [权利要求 8] 根据权利要求 4所述的仿生皮肤的制备方法, 其特征在于: 所述降粘 齐抱括 Dow Corning  [Claim 8] The method for preparing bionic skin according to claim 4, wherein: the viscosity reduction includes Dow Corning Corporation公司聚二甲基硅氧烷和三硅氧烷 PMX- 1184产品 10- 14份、 Dow Corning Corporation公司聚二甲基硅氧烷 PMX-200产品 1-5份; 所 述乳化剂包括 Shin-Etsu Chemical Corporation's polydimethylsiloxane and trisiloxane PMX-1184 products 10-14 parts, Dow Corning Corporation polydimethylsiloxane PMX-200 products 1-5 parts; Emulsifiers include Shin-Etsu Chemical Corporation公司聚二甲基硅氧院 /PEG-10/15交联聚合物和十甲基环五 硅氧烷 KSG-240产品 3-7份、 Dow Corning  Corporation Polydimethylsiloxane/PEG-10/15 Crosslinked Polymer and Decamethylcyclopentasiloxane KSG-240 3-7 copies, Dow Corning Corporation公司二异丁基 PEG/PPG- 10/7/聚二甲基硅氧烷共聚物 FZ-22 33产品 0.05-0.3份; 所述增稠剂包括 Lubrizol  Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-22 33 product 0.05-0.3 parts; the thickener includes Lubrizol Corporation公司丙烯酸酯 /C 10-30烷基丙烯酸酯交联聚合物 Pemulen TR-2产品 0.1-0.7份、 Lubrizol Corporation公司丙烯酸酯 /C10-30烷基丙 烯酸酯交联聚合物 Ultrez  Corporation Acrylate / C 10-30 Alkyl Acrylate Crosslinked Polymer Pemulen TR-2 Product 0.1-0.7 parts, Lubrizol Corporation Acrylate / C10-30 Alkyl Acrylate Crosslinked Polymer Ultrez 20产品 0.1-0.7份, 所述保湿剂包括苯氧乙醇 0.1-0.5份、 戊二醇和辛乙 二醇 1: 1的二醇混合物 0.1-0.5份。  20 products 0.1-0.7 parts, the humectant comprising 0.1-0.5 parts of phenoxyethanol, 0.1-0.5 parts of a diol mixture of pentanediol and octylene glycol 1:1. [权利要求 9] 根据权利要求 6所述的仿生皮肤的制备方法, 其特征在于: 所述增稠 剂包括 Dow Corning Corporation公司十甲基环五硅氧烷和聚二甲基硅 氧烷聚合物 DC9045产品 8- 13份、 Dow Corning Corporation公司聚二甲 基硅氧烷交联共聚物和环五甲基硅氧烷 DC9040产品 1-3份、 氯化钠 0.3 -0.7份; 所述铺展剂包括 Shin-Etsu Chemical Corporation公司环五聚二 甲基硅氧烷 KF-995产品 13-18份、 Dow Corning Corporation公司环五聚 二甲基硅氧烷 PMX-0245产品 0.1-3份; 所述保湿剂包括苯氧乙醇 0.1-0. 7份、 戊二醇和辛乙二醇 1: 1的二醇混合物 3-7份、 丙二醇 8-13份、 丁二 醇 8- 13份、 甘油 3-8份; 所述乳化剂包括 Shin-Etsu Chemical [Claim 9] The method for producing bionic skin according to claim 6, wherein the thickener comprises Dow Corning Corporation, decamethylcyclopentasiloxane and polydimethylsiloxane polymer 8 to 13 parts of DC9045, 1-3 parts of Dow Corning Corporation polydimethylsiloxane crosslinked copolymer and cyclopentamethylsiloxane DC9040, and 0.3 to 0.7 parts of sodium chloride; the spreading agent includes 13-18 parts of cyclopentapolydimethylsiloxane KF-995 product of Shin-Etsu Chemical Corporation, 0.1-3 parts of Dow Corning Corporation cyclopentadimethylsiloxane PMX-0245 product; the humectant Including phenoxyethanol 0.1-0. 7 parts, pentanediol and octylene glycol 1:1 mixture of diol 3-7 parts, propylene glycol 8-13 parts, butanediol 8-13 parts, glycerol 3-8 parts; The emulsifier includes Shin-Etsu Chemical Corporation公司聚二甲基硅氧院 /PEG-10/15交联聚合物和十甲基环五 硅氧烷 KSG-240产品 2-7份、 Dow Corning  Corporation Polydimethylsiloxane/PEG-10/15 Crosslinked Polymer and Decamethylcyclopentasiloxane KSG-240 2-7, Dow Corning Corporation公司二异丁基 PEG/PPG- 10/7/聚二甲基硅氧烷共聚物 FZ-22 33产品 0.1-0.3份。  Corporation diisobutyl PEG/PPG-10/7/polydimethylsiloxane copolymer FZ-22 33 product 0.1-0.3 parts.
PCT/CN2017/100138 2016-12-16 2017-09-01 Bionic skin and preparation method therefor Ceased WO2018107821A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611167553.1A CN106668937A (en) 2016-12-16 2016-12-16 Bionic skin and preparation method thereof
CN201611167553.1 2016-12-16

Publications (1)

Publication Number Publication Date
WO2018107821A1 true WO2018107821A1 (en) 2018-06-21

Family

ID=58869651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/100138 Ceased WO2018107821A1 (en) 2016-12-16 2017-09-01 Bionic skin and preparation method therefor

Country Status (2)

Country Link
CN (1) CN106668937A (en)
WO (1) WO2018107821A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106668937A (en) * 2016-12-16 2017-05-17 深圳市茵冠生物科技有限公司 Bionic skin and preparation method thereof
CN109966176A (en) * 2017-12-28 2019-07-05 伊丽英 Skin wrinkle-removing composition and application thereof
CN108567997B (en) * 2018-06-04 2021-03-09 上海其鸿新材料科技有限公司 High-strength elastic invisible artificial skin
CN108524330A (en) * 2018-06-04 2018-09-14 上海其鸿新材料科技有限公司 A kind of one-component coating fluid and preparation method thereof of the stealthy skin of elasticity
CN110559212A (en) * 2019-10-14 2019-12-13 南京医科大学 Polysiloxane moisturizing and wrinkle removing mask and using method thereof
JP7356335B2 (en) * 2019-12-23 2023-10-04 花王株式会社 Method for producing colored nonwoven fabric
CN115243733B (en) * 2020-03-17 2024-11-12 株式会社资生堂 Composition for forming artificial skin and method of using the same
CN113740491B (en) * 2021-08-27 2025-03-25 无限极(中国)有限公司 A kind of artificial skin for sensory evaluation and preparation method thereof
CN114010539B (en) * 2021-10-29 2022-11-01 华中科技大学 Bionic polymer film for beauty treatment and preparation method and application thereof
CN115177552A (en) * 2022-07-11 2022-10-14 杭州归领医疗器械有限公司 Bionic skin cream capable of immediately covering wrinkles and preparation method thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1805761A (en) * 2003-06-10 2006-07-19 莫恩里克保健股份公司 Elastomer-forming barrier preparation
CN101862474A (en) * 2009-09-30 2010-10-20 中国人民解放军第四军医大学 Addition type face prosthesis silicon rubber and preparation method thereof
WO2011001221A1 (en) * 2009-07-03 2011-01-06 L'oreal Cosmetic process for coating keratin material
US20120237461A1 (en) * 2010-08-31 2012-09-20 Betty Yu Skin compositions and methods of use thereof
CN103153279A (en) * 2010-08-31 2013-06-12 生活实验公司 Skin compositions and methods of use thereof
WO2014019840A2 (en) * 2012-08-01 2014-02-06 Dow Corning Corporation Aqueous silicone dispersions and their preparation
CN104136568A (en) * 2011-12-21 2014-11-05 道康宁公司 Hydrophilic silicone gel adhesives
CN106668937A (en) * 2016-12-16 2017-05-17 深圳市茵冠生物科技有限公司 Bionic skin and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497968A (en) * 2016-01-22 2016-04-20 贵州康琦药械有限公司 Manufacturing method of scar patch

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1805761A (en) * 2003-06-10 2006-07-19 莫恩里克保健股份公司 Elastomer-forming barrier preparation
WO2011001221A1 (en) * 2009-07-03 2011-01-06 L'oreal Cosmetic process for coating keratin material
CN101862474A (en) * 2009-09-30 2010-10-20 中国人民解放军第四军医大学 Addition type face prosthesis silicon rubber and preparation method thereof
US20120237461A1 (en) * 2010-08-31 2012-09-20 Betty Yu Skin compositions and methods of use thereof
CN103153279A (en) * 2010-08-31 2013-06-12 生活实验公司 Skin compositions and methods of use thereof
CN104136568A (en) * 2011-12-21 2014-11-05 道康宁公司 Hydrophilic silicone gel adhesives
WO2014019840A2 (en) * 2012-08-01 2014-02-06 Dow Corning Corporation Aqueous silicone dispersions and their preparation
CN106668937A (en) * 2016-12-16 2017-05-17 深圳市茵冠生物科技有限公司 Bionic skin and preparation method thereof

Also Published As

Publication number Publication date
CN106668937A (en) 2017-05-17

Similar Documents

Publication Publication Date Title
WO2018107821A1 (en) Bionic skin and preparation method therefor
CN102449073B (en) Film forming, silicone containing compositions
CN103079538B (en) Cosmetics for hair containing co-modified organopolysiloxane
CA2307996C (en) Organopolysiloxane gels for use in cosmetics
CN102056588B (en) Cosmetic
JP5570764B2 (en) Cosmetics
JP5373046B2 (en) Oil-in-water emulsion composition
KR101050719B1 (en) Silicone resin coated titanium dioxide composite particles, preparation method thereof and cosmetic composition comprising the same
EP3009466B1 (en) Silicone modified by long-chain hydrocarbon group-containing diglycerin derivative, and use thereof
WO2020142388A1 (en) Composition, method of preparing copolymer, and methods and end uses thereof
JP2001011281A (en) Composition containing elastomer silicone polyether
EP3292858B1 (en) Cosmetic and method for manufacturing the same
JP7720830B2 (en) Composition for forming artificial skin and method of using same
US8236890B2 (en) Emulsions of silicone elastomer and silicone organic elastomer gels
EP2641929B1 (en) Novel organopolysiloxane, cosmetic containing thereof, and method for preparing organopolysiloxane
JP2001288365A (en) Composition in water-in-oil emulsion form and its use for cosmetics
KR20180113600A (en) Composition and Manufacturing Method
EP3589674A1 (en) Silicone urethane urea copolymer and preparation and use thereof
EP2581401A1 (en) Glycerol group-containing organopolysiloxane, cosmetic, and method for producing glycerol group-containing organopolysiloxane
CN108567997B (en) High-strength elastic invisible artificial skin
CN116437972A (en) Oil-in-water emulsion composition comprising platinum catalyst and method of use thereof
JP2003055134A (en) External preparation composition
JP5128201B2 (en) Makeup base
CN107304295B (en) A kind of preparation method of MQ resin reinforced silicone elastic silica gel film
JP2001048729A (en) Cosmetic and the production thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17881209

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17881209

Country of ref document: EP

Kind code of ref document: A1